LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced that it will share new data from its gene ... in oral and poster presentations at the American Society of Gene and ...

LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced that it will share new data from its gene therapy programs in Gaucher disease, GBA1 Parkinson's disease and ...

The poster will include clinical data as of an April 4 ... Abstract and poster presentation details are below: Title: “Phase 1 dose escalation results of the WEE1 inhibitor, azenosertib ...

today announced that data on the long term efficacy and safety of its ALXN1840 (tiomolybdate choline) drug candidate for Wilson disease has been accepted for a late-breaker poster presentation at ...

ClearB Therapeutics, Inc., a company developing therapeutic vaccines designed to drive a functional cure for Hepatitis B, announced today that an abstract will be presented as a poster at the ...

IBM has evolved the watsonx.data platform to address roadblocks in scaling generative and agent-based AI, especially the need ...

“We are excited to share preclinical data on our therapeutic vaccine candidate, CLB-4000, with the Hepatitis B community,” said Aileen Rubio, PhD, CEO of ClearB Therapeutics. “Chronic ...